Search results :

Exenatide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: A10BX04

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Nausea Nausea postmarketing — 1.3% - 44% 0% - 18% x x x x x
Diarrhoea Diarrhoea postmarketing — 3.59% - 20% 3% - 8% x x x x x
Upper respiratory tract infection Upper respiratory tract infection 1.35% - 17.2% x
Nervousness Feeling jittery 9% 4% x x x x
Feeling jittery Feeling jittery 9% 4% x x x x
Headache Headache 4.24% - 14% 4% - 6% x x x x x
Pruritus Pruritus 8% x x x
Viral diarrhoea Viral diarrhoea 0% - 8.8% x x
Injection site haematoma Injection site haematoma 0.897% - 11% x x
Urinary tract infection Urinary tract infection 0.448% - 8.28% x
Dizziness Dizziness 1.35% - 9% 6% x x x x x
Injection site pruritus Injection site pruritus 0.448% - 18.2% x x x
Asthenia Asthenia 4% - 5% 1% - 2% x x x x
Fatigue 0% - 6.1% x x x
Nasopharyngitis Nasopharyngitis 2.41% - 17.9% x
Back pain Back pain 3.03% - 4.22% x
Erythema Erythema 4% x x x
Vomiting Vomiting postmarketing — 1% - 18.6% 0% - 4% x x x x x
Induration Induration 4% x
Injection site nodule Injection site nodule 0% - 10.5% x x
Dyspepsia Dyspepsia 0.897% - 7.4% 0% - 3% x x x x x
Constipation Constipation postmarketing — 1.2% - 10.1% 2% x x x x x
Fatigue Fatigue 0% - 6.1% x x x
Gastrooesophageal reflux disease Gastrooesophageal reflux disease 0.897% - 7.4% 0% - 1% x x x x x
Hyperhidrosis Hyperhidrosis 3% 1% x x x x
Nodule Nodule 3% x x x
Sinusitis Sinusitis 1.2% - 6.9% x
Hypertension Hypertension 1.21% - 3.14% x
Injection site erythema Injection site erythema 0% - 7.4% x x x
Influenza Influenza 1.2% - 3.14% x
Arthralgia Arthralgia 0% - 4.82% x
Musculoskeletal discomfort Arthralgia 0% - 4.82% x
Cough Cough 1.2% - 3.59% x
Musculoskeletal pain Musculoskeletal pain 0% - 3.14% x
Gastroenteritis Gastroenteritis 0% - 2.03% x
Toothache Toothache 1.01% - 2.42% x
Abdominal pain upper Abdominal pain upper 0.897% - 3.61% x
Oropharyngeal pain Oropharyngeal pain 0.602% - 3.59% x
Pain in extremity Pain in extremity 0.69% - 2.41% x
Anxiety Anxiety 0.606% - 2.07% x
Decreased appetite Decreased appetite 0% - 5% 0% x x x x x
Anorexia 0% - 2.03% x
Depression Depression 0% - 2.76% x
Injection site pain Injection site pain 0% - 2.07% x
Muscle spasms Muscle spasms 0.448% - 2.07% x
Abdominal pain Abdominal pain postmarketing — 0.897% - 3.61% x x x x x
Gastrointestinal pain Abdominal pain postmarketing — 0.897% - 3.61% x x x x x
Insomnia Insomnia 0.448% - 2.76% x
Hypoglycaemia Hypoglycaemia 0% - 43.5% x x x x x
Injection site induration Injection site induration 0% - 3.89% x
Abdominal discomfort Abdominal discomfort 0% - 2.2% x
Diabetic neuropathy Diabetic neuropathy 0% - 2.07% x
Erectile dysfunction Erectile dysfunction 0% - 2.76% x
Procedural pain Procedural pain 0% - 3.45% x
Abdominal distension Abdominal distension postmarketing — 4% 1% x x x x x
Pancreatitis acute Pancreatitis acute postmarketing, rare x x x
Alopecia Alopecia postmarketing — 0% - 2.07% x x x x x
Anaphylactic shock Anaphylactic shock very rare, postmarketing x x x x x
Angioedema Angioedema postmarketing, rare x x x x x
Dehydration Dehydration postmarketing, rare x x x x x
Dysgeusia Dysgeusia postmarketing, uncommon x x x x x
Eructation Eructation postmarketing, uncommon x x x x x
Flatulence Flatulence postmarketing — 2% 1% x x x x x
Haemorrhage Haemorrhage postmarketing x x x x x
Haemoglobin Haemorrhage postmarketing x x x x x
Hypersensitivity Hypersensitivity postmarketing x x
Renal failure acute Renal failure acute postmarketing, rare x x x x x
Renal failure chronic Renal failure chronic postmarketing, rare x x x x
Urethral disorder Urinary tract disorder postmarketing x x x x x
Urinary tract disorder Urinary tract disorder postmarketing x x x x x
Urticaria Urticaria postmarketing, rare x x x x x
Weight decreased Weight decreased rare x x x
Injection site reaction Injection site reaction postmarketing, common x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x
Pancreatitis necrotising Pancreatitis necrotising postmarketing x x
Pruritus generalised Pruritus generalised postmarketing, rare x x x
Drug interaction Drug interaction postmarketing x x x
Blood creatinine increased Serum creatinine increased postmarketing, rare x x x x x
Rash papular Rash papular postmarketing, rare x x x x x
Renal failure Renal impairment postmarketing, rare x x x x x
Renal failure x
Renal impairment Renal impairment postmarketing, rare x x x x x
Somnolence Somnolence postmarketing, rare x x x x x
Ischaemia Ischaemia very rare x
Colitis ischaemic Colitis ischaemic very rare x
Ileus Ileus very rare x
Alveolitis allergic Alveolitis allergic x
Mental disorder Mental disorder x
Breast disorder Breast disorder x
Chest pain Chest pain x
Coma Coma x
Infection Infection x
Connective tissue disorder Connective tissue disorder x
Gastrointestinal disorder Gastrointestinal disorder x x x
Hypokalaemia Hypokalaemia 0% - 2.76% x
Immune system disorder Immune system disorder x x x
Mediastinal disorder Mediastinal disorder x
Nervous system disorder Nervous system disorder x x x
Convulsion Convulsion x
Tachycardia Tachycardia x
Loss of consciousness Loss of consciousness x
Angiopathy Angiopathy x
Chills Chills x
Injection site mass Injection site mass x
Malnutrition Malnutrition x x x
Diabetes mellitus Diabetic x x
Neuroglycopenia Neuroglycopenia x
Injection site dermatitis Injection site dermatitis x
Blood glucose decreased Blood glucose decreased x
Infestation Infestation NOS x
International normalised ratio increased International normalised ratio increased x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

exenatide / exenatide

Side effects:41
Source:EMA

exenatide / exenatide

Side effects:49
Source:EMA

exenatide

Side effects:41
Source:FDA Structured Product Label

exenatide

Side effects:50
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label